Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Aug;103(4):1951–1957. doi: 10.1111/j.1476-5381.1991.tb12358.x

Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity.

R M Eglen 1, W W Montgomery 1, R L Whiting 1
PMCID: PMC1908190  PMID: 1680517

Abstract

1. Apparent affinity constants (KD) for prenalterol, an agonist of low intrinsic efficacy at beta 1-adrenoceptors in rat left atria, have been determined by use of receptor desensitization and functional antagonism induced by isoprenaline and carbachol, respectively. The values obtained have been compared to those values estimated with the irreversible beta-adrenoceptor antagonist, bromoacetylalprenololmenthane (BAAM). 2. The -log KD values for prenalterol estimated by desensitization or irreversible antagonism ranged from 6.8-7.1 and 6.2-7.1, respectively. 3. Carbachol produced functional antagonism of the response to prenalterol even though it was removed before addition of prenalterol. This effect was mediated by M2-muscarinic receptors. Pretreatment of animals with pertussis toxin did not affect the functional antagonism elicited by carbachol. The apparent KD value obtained after pre-exposure to carbachol (6.8) was similar to those estimated by use of either alkylation with BAAM or desensitization with isoprenaline (see above). 4. It is concluded that acute desensitization or functional antagonism of responses to agonists of low intrinsic efficacy provides a means to estimate apparent KD constants. This approach could be useful to characterize receptors for which an irreversible antagonist may not be available.

Full text

PDF
1951

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bevan J. A., Bevan R. D., Shreeve S. M. Variable receptor affinity hypothesis. FASEB J. 1989 Apr;3(6):1696–1704. doi: 10.1096/fasebj.3.6.2564831. [DOI] [PubMed] [Google Scholar]
  2. Black J. W., Gerskowitch V. P., Leff P., Shankley N. P. Pharmacological analysis of beta-adrenoceptor-mediated agonism in the guinea-pig, isolated, right atrium. Br J Pharmacol. 1985 Mar;84(3):779–785. doi: 10.1111/j.1476-5381.1985.tb16161.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Broadley K. J., Nicholson C. D. Functional antagonism as a means of determining dissociation constants and relative efficacies of sympathomimetic amines in guinea-pig isolated atria. Br J Pharmacol. 1979 Jul;66(3):397–404. doi: 10.1111/j.1476-5381.1979.tb10844.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buckner C. K., Saini R. K. On the use of functional antagonism to estimate dissociation constants for beta adrenergic receptor agonists in isolated guinea-pig trachea. J Pharmacol Exp Ther. 1975 Sep;194(3):565–574. [PubMed] [Google Scholar]
  5. Doggrell S. A. The effects of beta-adrenoreceptor antagonists on the force responses of the electrically driven rat right ventricle strip to isoprenaline. J Auton Pharmacol. 1989 Aug;9(4):265–277. doi: 10.1111/j.1474-8673.1989.tb00217.x. [DOI] [PubMed] [Google Scholar]
  6. Eglen R. M., Montgomery W. W., Whiting R. L. Negative and positive inotropic responses to muscarinic agonists in guinea pig and rat atria in vitro. J Pharmacol Exp Ther. 1988 Dec;247(3):911–917. [PubMed] [Google Scholar]
  7. Eglen R. M., Whiting R. L. Estimation of apparent agonist affinity constants using desensitization of the ileal muscarinic receptor. J Pharmacol Exp Ther. 1987 Feb;240(2):404–409. [PubMed] [Google Scholar]
  8. Eglen R. M., Whiting R. L. Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature. J Auton Pharmacol. 1986 Dec;6(4):323–346. doi: 10.1111/j.1474-8673.1986.tb00661.x. [DOI] [PubMed] [Google Scholar]
  9. Green J. P. Pharmacological receptors: the need for a compendium of classification, nomenclature and structure. Trends Pharmacol Sci. 1990 Jan;11(1):13–16. doi: 10.1016/0165-6147(90)90035-7. [DOI] [PubMed] [Google Scholar]
  10. Gurden J. M., Apperley G. H., Drew G. M. A comparison of the properties of prenalterol and corwin at beta 1- and beta 2-adrenoreceptors in vitro. J Auton Pharmacol. 1989 Apr;9(2):79–91. doi: 10.1111/j.1474-8673.1989.tb00199.x. [DOI] [PubMed] [Google Scholar]
  11. Harden T. K. Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev. 1983 Mar;35(1):5–32. [PubMed] [Google Scholar]
  12. Herepath M. L., Broadley K. J. Desensitization of beta-adrenoceptor-mediated functional responses of guinea pig atria by in vitro incubation with isoprenaline. J Cardiovasc Pharmacol. 1990 Feb;15(2):259–268. doi: 10.1097/00005344-199002000-00013. [DOI] [PubMed] [Google Scholar]
  13. Juberg E. N., Minneman K. P., Abel P. W. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart. Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):193–202. doi: 10.1007/BF00572434. [DOI] [PubMed] [Google Scholar]
  14. Kenakin T. P., Beek D. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure. J Pharmacol Exp Ther. 1982 Jan;220(1):77–85. [PubMed] [Google Scholar]
  15. Kenakin T. P., Beek D. Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number. J Pharmacol Exp Ther. 1984 May;229(2):340–345. [PubMed] [Google Scholar]
  16. Kenakin T. P., Boselli C. Promiscuous or heterogeneous muscarinic receptors in rat atria? I. Schild analysis with simple competitive antagonists. Eur J Pharmacol. 1990 Nov 20;191(1):39–48. doi: 10.1016/0014-2999(90)94094-e. [DOI] [PubMed] [Google Scholar]
  17. Kenakin T. P. Challenges for receptor theory as a tool for drug and drug receptor classification. Trends Pharmacol Sci. 1989 Jan;10(1):18–22. doi: 10.1016/0165-6147(89)90102-8. [DOI] [PubMed] [Google Scholar]
  18. Leff P., Harper D., Dainty I. A., Dougall I. G. Pharmacological estimation of agonist affinity: detection of errors that may be caused by the operation of receptor isomerisation or ternary complex mechanisms. Br J Pharmacol. 1990 Sep;101(1):55–60. doi: 10.1111/j.1476-5381.1990.tb12088.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Leff P., Martin G. R., Morse J. M. Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants. Br J Pharmacol. 1985 Jul;85(3):655–663. doi: 10.1111/j.1476-5381.1985.tb10561.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Leff P., Martin G. R. The classification of 5-hydroxytryptamine receptors. Med Res Rev. 1988 Apr-Jun;8(2):187–202. doi: 10.1002/med.2610080203. [DOI] [PubMed] [Google Scholar]
  21. Lohse M. J., Benovic J. L., Caron M. G., Lefkowitz R. J. Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem. 1990 Feb 25;265(6):3202–3211. [PubMed] [Google Scholar]
  22. Mackay D. Agonist potency and apparent affinity: interpretation using classical and steady-state ternary-complex models. Trends Pharmacol Sci. 1990 Jan;11(1):17–22. doi: 10.1016/0165-6147(90)90036-8. [DOI] [PubMed] [Google Scholar]
  23. Mackay D. An analysis of functional antagonism and synergism. Br J Pharmacol. 1981 May;73(1):127–134. doi: 10.1111/j.1476-5381.1981.tb16781.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mackay D. Continuous variation of agonist affinity constants. Trends Pharmacol Sci. 1988 May;9(5):156–157. doi: 10.1016/0165-6147(88)90026-0. [DOI] [PubMed] [Google Scholar]
  25. Molenaar P., Malta E. Analysis of agonist dissociation constants as assessed by functional antagonism in guinea pig left atria. J Pharmacol Methods. 1986 Apr;15(2):105–117. doi: 10.1016/0160-5402(86)90060-4. [DOI] [PubMed] [Google Scholar]
  26. Molenaar P., McPherson G. A., Malta E., Raper C. The influence of molecular structure on the affinity and efficacy of some beta-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol. 1985 Nov;331(2-3):240–246. doi: 10.1007/BF00634244. [DOI] [PubMed] [Google Scholar]
  27. Ng N. L., Malta E. Organ-bath studies using the irreversible beta-adrenoreceptor antagonist bromoacetylalprenololmenthane (BAAM). J Auton Pharmacol. 1989 Jun;9(3):189–200. doi: 10.1111/j.1474-8673.1989.tb00210.x. [DOI] [PubMed] [Google Scholar]
  28. O'Donnell S. R., Wanstall J. C. The use of functional antagonism to determine whether beta-adrenoceptor agonists must have a lower efficacy than isoprenaline to be trachea-atria selective in vitro in guinea-pigs. Br J Pharmacol. 1977 Jun;60(2):255–262. doi: 10.1111/j.1476-5381.1977.tb07748.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Parker R. B., Waud D. R. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther. 1971 Apr;177(1):1–12. [PubMed] [Google Scholar]
  30. Posner P., Peterson C. V., Pitha J., Baker S. P. The effect of bromoacetylalprenololmentane on rat atrial tension development and beta-adrenoreceptors. Eur J Pharmacol. 1984 May 4;100(3-4):373–376. doi: 10.1016/0014-2999(84)90016-5. [DOI] [PubMed] [Google Scholar]
  31. VAN ROSSUM J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963;143:299–330. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES